Four clinical trials studied the effect of probiotics on residual beta cell function by measuring (area under the curve) C-peptide levels, reflective of endogenous insulin production, in children with new-onset T1D [143,144,145,146]. This evidence concerns the gene INS and type 1 diabetes mellitus.